Krishna Institute of Medical Sciences (NSE:KIMS) Revenue: ₹42,125 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KIMS Krishna Institute of Medical Sciences Ltd NSE:KIMS
87 GF Score
Price ₹807.55
GF Value ₹859.12
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Krishna Institute of Medical Sciences Revenue?

Krishna Institute of Medical Sciences NSE:KIMS +0.45% 87 Revenue is ₹42,125 Mil as of Jun. 2026. GuruFocus rates NSE:KIMS with a GF Score™ of 87/100 and a GF Value™ of ₹859.12 (Fairly Valued). The stock has 6 warning signs investors should review.

Krishna Institute of Medical Sciences's revenue for the three months ended in Jun. 2026 was ₹11,795 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₹42,125 Mil. Krishna Institute of Medical Sciences's Revenue per Share for the three months ended in Jun. 2026 was ₹29.56. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹105.19.

During the past 12 months, the average Revenue per Share Growth Rate of Krishna Institute of Medical Sciences was 30.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, Krishna Institute of Medical Sciences's highest 3-Year average Revenue per Share Growth Rate was 24.50% per year. The lowest was 21.30% per year. And the median was 21.90% per year.


Krishna Institute of Medical Sciences  (NSE:KIMS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Krishna Institute of Medical Sciences Revenue Related Terms


Krishna Institute of Medical Sciences Revenue Historical Data

* Premium members only.

The historical data trend for Krishna Institute of Medical Sciences's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krishna Institute of Medical Sciences Revenue Chart

Krishna Institute of Medical Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Revenue
Get a 7-Day Free Trial 16,508.25 21,676.64 24,740.00 30,035.00 38,721.00

Krishna Institute of Medical Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,716.00 9,607.00 9,977.00 10,746.00 11,795.00

NSE:KIMS vs HCA, THC, DVA: Revenue Comparison

For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krishna Institute of Medical Sciences Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Revenue distribution charts can be found below:

* The bar in red indicates where Krishna Institute of Medical Sciences's Revenue falls into.


NSE:KIMS
87GF Score
Krishna Institute of Medical Sciences Ltd NSE:KIMS
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krishna Institute of Medical Sciences Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹42,125 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₹42,125 Mil mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a Revenue of ₹42,125 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Krishna Institute of Medical Sciences and its competitors.
Is Krishna Institute of Medical Sciences' Revenue too high?
Krishna Institute of Medical Sciences' current Revenue is ₹42,125 Mil. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Revenue compare to HCA and THC?
Krishna Institute of Medical Sciences' Revenue of ₹42,125 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Krishna Institute of Medical Sciences and its competitors. Krishna Institute of Medical Sciences's current Revenue is ₹42,125 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹859.12, compared to a current price of ₹807.55 — trading 6% below its estimated fair value. The current Revenue is ₹42,125 Mil. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Revenue is ₹42,125 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be undervalued. The current stock price of ₹807.55 is trading 6% below its estimated GF Value™ of ₹859.12. GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.

Key valuation signals for NSE:KIMS:

  • Revenue: ₹42,125 Mil
  • GF Value™: ₹859.12 vs. price of ₹807.55 (6% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krishna Institute of Medical Sciences Business Description

Other Exchanges 543308:India
Address D. No. 1-8-31/1, Minister Road, Secunderabad, TG, IND, 500 003
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score

Get the complete analysis for NSE:KIMS

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹807.55
Price
₹859.12
GF Value